BDBM141402 US10668051, Compound Example 28::US8921364, 28

SMILES Cc1nnsc1C(=O)Nc1ccc(c(F)c1)-n1nc(cc1C1CC1)C1CC1

InChI Key InChIKey=UOXHLYMLCPPNGX-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 141402   

TargetEF-hand calcium-binding domain-containing protein 4B(Human)
Rhizen Pharmaceuticals

US Patent
LigandPNGBDBM141402(US8921364, 28 | US10668051, Compound Example 28)
Affinity DataIC50: 60.3nMT: 2°CAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Rhizen Pharmaceuticals

US Patent
LigandPNGBDBM141402(US8921364, 28 | US10668051, Compound Example 28)
Affinity DataIC50: 60.3nMAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur...More data for this Ligand-Target Pair
In DepthDetails
US Patent